Progesterone
- CAS No.
- 57-83-0
- Chemical Name:
- Progesterone
- Synonyms
- Lutein;PROCYANIDINS;Progestrone;Progesteron;Lutin;progestin;Pregn-4-ene-3,20-dione;Prog;Luteine;Prometrium
- CBNumber:
- CB4224484
- Molecular Formula:
- C21H30O2
- Molecular Weight:
- 314.46
- MDL Number:
- MFCD00003658
- MOL File:
- 57-83-0.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Progesterone for peak identification European Pharmacopoeia (EP) Reference Standard | Y0001666 | 5 mg | $254 |
| Progesterone for system suitability European Pharmacopoeia (EP) Reference Standard | Y0001665 | 5 mg | $254 |
| Progesterone European Pharmacopoeia (EP) Reference Standard | P3300000 | 120 mg | $254 |
| Progesterone solution 1.0?mg/mL in acetonitrile, ampule of 1?mL, certified reference material, Cerilliant? | P-069 | 1mL | $152 |
| Progesterone British Pharmacopoeia (BP) Reference Standard | BP449 | 50MG | $256 |
| More product size | |||
| Melting point | 128-132 °C (lit.) |
|---|---|
| alpha | 186 º (c=1, ethanol) |
| Boiling point | 394.13°C (rough estimate) |
| Density | d23 1.166; d20 1.171 |
| refractive index | 182 ° (C=2, Dioxane) |
| Flash point | 2℃ |
| storage temp. | room temp |
| solubility | H2O: 25 mg/mL, may be clear to slightly hazy |
| form | powder |
| color | Yellow to yellow-brown |
| biological source | synthetic (organic) |
| Water Solubility | <0.1 g/100 mL at 19 ºC |
| Merck | 7773 |
| BRN | 1915950 |
| Henry's Law Constant | 1.5×102 mol/(m3Pa) at 25℃, HSDB (2015) |
| BCS Class | 4 |
| Stability | Stable. Incompatible with strong oxidizing agents. |
| Major Application | pharmaceutical (small molecule) |
| Cosmetics Ingredients Functions | SKIN CONDITIONING |
| InChI | 1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1 |
| InChIKey | RJKFOVLPORLFTN-LEKSSAKUSA-N |
| SMILES | CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C |
| LogP | 3.870 |
| FDA 21 CFR | 556.540 |
| CAS DataBase Reference | 57-83-0(CAS DataBase Reference) |
| EWG's Food Scores | 4-7 |
| NCI Dictionary of Cancer Terms | progesterone; progestin |
| FDA UNII | 4G7DS2Q64Y |
| ATC code | G03DA04 |
| NCI Drug Dictionary | Lutex |
| NIST Chemistry Reference | Progesterone(57-83-0) |
| Proposition 65 List | Progesterone |
| EPA Substance Registry System | Progesterone (57-83-0) |
| UNSPSC Code | 51111800 |
| NACRES | NA.77 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Danger | |||||||||
| Hazard statements | H351-H360FD-H362 | |||||||||
| Precautionary statements | P202-P260-P263-P264-P270-P308+P313 | |||||||||
| PPE | Eyeshields, Gloves, type P3 (EN 143) respirator cartridges | |||||||||
| Hazard Codes | Xn,T,F | |||||||||
| Risk Statements | 40-45-62-36-20/21/22-11 | |||||||||
| Safety Statements | 36/37-45-53-16 | |||||||||
| RIDADR | UN 1648 3 / PGII | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | TW0175000 | |||||||||
| TSCA | TSCA listed | |||||||||
| HS Code | 29372390 | |||||||||
| Storage Class | 6.1C - Combustible acute toxic Cat.3 toxic compounds or compounds which causing chronic effects |
|||||||||
| Hazard Classifications | Carc. 2 Lact. Repr. 1A |
|||||||||
| Hazardous Substances Data | 57-83-0(Hazardous Substances Data) | |||||||||
| Toxicity | LD50 intraperitoneal in rat: 327mg/kg | |||||||||
| NFPA 704 |
|
Progesterone price More Price(60)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | Y0001666 | Progesterone for peak identification European Pharmacopoeia (EP) Reference Standard | 57-83-0 | 5 mg | $254 | 2026-03-19 | Buy |
| Sigma-Aldrich | Y0001665 | Progesterone for system suitability European Pharmacopoeia (EP) Reference Standard | 57-83-0 | 5 mg | $254 | 2026-03-19 | Buy |
| Sigma-Aldrich | P3300000 | Progesterone European Pharmacopoeia (EP) Reference Standard | 57-83-0 | 120 mg | $254 | 2026-03-19 | Buy |
| Sigma-Aldrich | P-069 | Progesterone solution 1.0?mg/mL in acetonitrile, ampule of 1?mL, certified reference material, Cerilliant? | 57-83-0 | 1mL | $152 | 2026-03-19 | Buy |
| Sigma-Aldrich | BP449 | Progesterone British Pharmacopoeia (BP) Reference Standard | 57-83-0 | 50MG | $256 | 2026-03-19 | Buy |
Progesterone Chemical Properties,Uses,Production
Description
Progesterone is a hormone released by luteal cells in the ovaries which contains 21 Carbon Atoms. Progesterone is also a crucial metabolic intermediate in the production of other endogenous steroids. There are two crystal forms of progesterone, that are type-α and type-β, the two types have similar physiological activity. Type-α is precipitated from dilute ethanol as orthorhombic white prismatic crystal, while type-β is orthorhombic white needle crystal, they are both insoluble in water, but soluble in ethanol, ethyl ether, chloroform, acetone, dioxane and concentrated sulfuric acid.
Progesterone can be released by the ovary, placenta and adrenal cortex. Its physiological function mainly manifests in promoting estrogen treated over thicken lining of the uterus to continue the development, proliferation and thickening and hypertrophy, soften and secretion of mucus in order to make good condition for implantation of the fertilized egg. After the implantation, early stage survival and development of fertilized egg is also under the control of the high progesterone release. As a result, progesterone is a very important hormone in the female reproductive system, and it is also an important intermediate in the biosynthesis of steroid hormones. All steroid hormone releasable glands can produce progesterone, but only ovarian and placenta can release progesterone as the main hormone. Ovarian will release large amount of progesterone in the luteal phase after ovulation by granulose luteal cells, so progesterone is also named as progestin. Progesterone will decrease in result of corpus luteum atrophy. For normal women, placenta will becomes the main organ maintain progesterone after 8 to 9 weeks of pregnancy, accompany with the ovary releasing until the end of pregnancy.
Uses
The main physiological effects of progesterone:
1. Progesterone can maintain the female animal pregnancy, and cause a series of physiological changes, such as inhibition of female estrus.
2. Progesterone has the power to promote the thickening of the lining of the uterus, promote the bending of the gland and to increase secretion function.
3. Progesterone can inhibit the peristalsis of the uterus, and contribute to the cervix contraction, secretion of mucus, etc.. These physiological changes provide suitable environment for the operation, growth and development of early embryos, as well as the continued growth of the fetus.
4. Small amount of progesterone is also used in combination with the hormone estrogen to promote female estrus. The synergy between progesterone and prolactin can promote the development of mammary glands.
5. Progesterone is involved in the feedback regulation of the hypothalamus and anterior pituitary, which makes the balance of the animal reproductive hormones. In vivo, progesterone content of all sorts of livestock follicular phase is below 1 ng/ml, while in bovine corpus luteum period is approximately 4 ng/ml, pregnancy period is about 18 ng/ml.
6. Formerly biochemical study shows that progesterone modulates action as progestogens, clinical for the treatment of habitual abortion, dysmenorrhea, amenorrhea and other symptoms. One of progesterone's most important functions is as hormone drugs, to promote and maintain the uterine changes in the early stage of pregnancy, used in habitual abortion, irregular menstruation, etc.. In addition, progesterone also behaves as steroid hormone drug as well as progestogens, which is used in treatment of threatened abortion.
Preparation
Progesterone can be obtained by oxidation of the pregnenolone. Dry toluene was added to a oven dried reaction kettle, and then cyclohexanone and pregnenolone were added in order with vigorous stirring to dissolve. Side product H2O was removed by Soxhlet extraction with toluene steam, aluminium isopropoxidequickly was added flowingly, the oxidation reaction was hold on at 115 oC for 2h, cooling to 80 oC, add 5% dilute sulfuric acid under stirring then stand by until water and toluene separated, the toluene layer was extracted with water to neutrality and then distillation off toluene and cyclohexanone. Cooling, filtering, filter cake was beated with petroleum, filtering, washing with petroleum, dried as crude progesterone. The crude product was dissolved in ethanol, decolorized by activated carbon, recrystallized to get the final product, yield 80%. Another way to produce progesterone is choosing the 16-Dehydropregnenolone acetate as start material, treated consecutively by catalytic hydrogenation, alkali hydrolysis, oxidation by aluminum isopropoxide, to get the progesterone as final product.
Description
Progesterone, along with pregnenolone, is the biosynthetic precursor of all other steroid hormones. Progesterone is synthesized from cholesterol by the sequential action of desmolase in the mitochondria, which produces pregnenolone, followed by Δ4,5-
Chemical Properties
White powder. Melting point 121°C. Stable in air. Insoluble in water. A female sex hormone. Low toxicity.
Occurrence
Colchicum luteum also yields this alkaloid.
Uses
Progesterone is used as a contraceptive, for amenorrhea, for premenopausal syndrome, infertility, incomplete pregnancies, and anovulatory uterine bleeding.
Uses
Steroid hormone produced by the corpus luteum. Induces maturation and secretory activity of the uterine endothelium; suppresses ovulation. Progesterone is implicated in the etiology of breast cancer.This compound is a contaminant of emerging concern (CECs).
Definition
ChEBI: Progesterone is a C21-steroid hormone in which a pregnane skeleton carries oxo substituents at positions 3 and 20 and is unsaturated at C(4)-C(5). As a hormone, it is involved in the female menstrual cycle, pregnancy and embryogenesis of humans and other species. It has a role as a contraceptive drug, a progestin, a progesterone receptor agonist, a human metabolite and a mouse metabolite. It is a 20-oxo steroid, a 3-oxo-Delta(4) steroid and a C21-steroid hormone. It derives from a hydride of a pregnane.
brand name
Crinone (Columbia); Prometrium (Unimed).
Biological Functions
Progesterone is a hormone, produced primarily by the corpus luteum of the ovary but also by the placenta, that prepares the inner lining of the uterus for implantation ofa fertilized egg cell. If implantation fails, the corpus luteum degenerates and progesterone production ceases accordingly. If implantation occurs,the corpus luteum continues to secrete progesterone, under the influence of luteinizing hormone and prolactin, for several months of pregnancy,by which time the placenta has taken over this function. Duringpregnancy, progesterone maintains the constitution of the uterus and prevents further release of eggs from the ovary. Small amounts of progesterone are produced by the testes.
General Description
Progesterone, pregn-4-en-3,20-dione, is so rapidly metabolized that it is not particularlyeffective orally, being only one twelfth as active as intramuscularly.An oral formulation of micronized progesterone(Prometrium) is available. Progesterone given intramuscularlycan be very irritating. A vaginal gel containing 4% or8% progesterone offers an alternative dosage form.Progesterone was originally obtained from animal ovariesbut is now prepared synthetically from plant sterol precursors.The discovery of 19-nortestosterones with progesteroneactivity made synthetically modified progestins of tremendoustherapeutic importance.
Progesterone (and all other steroid 4-ene-3-ones) is lightsensitive and should be protected from light.
Air & Water Reactions
Insoluble in water.
Reactivity Profile
Progesterone is sensitive to light .
Hazard
A carcinogen (OSHA).
Health Hazard
ACUTE/CHRONIC HAZARDS: Progesterone may be absorbed through the skin.
Fire Hazard
Flash point data for Progesterone are not available; however, Progesterone is probably combustible.
Biological Activity
Endogenous progesterone receptor (PR) agonist (EC 50 = 0.5 nM).
Biochem/physiol Actions
Induces maturation and secretory activity of the uterine endothelium; suppresses ovulation. Progesterone is implicated in the etiology of breast cancer.
Pharmacology
During the second half of the menstrual cycle, progesterone promotes glandular growth in the endometrium, hyperemia of the uterus, thickening of the endometrium in preparation for implantation of a fertilized egg, and reduces the excitability of the uterus during pregnancy, inhibiting its activity and relaxing smooth muscles , allowing the embryo to grow safely. Under the joint action of estrogen, progesterone promotes the development of breast lobules and glands, so that the breasts can fully develop and prepare for lactation. Progesterone closes the cervix, reduces and thickens the mucus, and makes it difficult for sperm to penetrate; in large doses, it inhibits the secretion of pituitary gonadotropin through a negative feedback effect on the hypothalamus, resulting in the inhibition of ovulation. After ovulation, on the basis of the action of progesterone hormone, the endometrium continues to thicken and hyperemia, the glands proliferate and branch, from the proliferative phase to the secretory phase, which is conducive to the implantation and embryonic development of pregnant eggs. Progesterone inhibits uterine contractions and reduces the sensitivity of the uterus to oxytocin, allowing the fetus to grow safely. Progesterone competes against aldosterone, thereby promoting Na and Cl excretion and diuresis. Progesterone can slightly increase body temperature in normal women, so the basal body temperature in the luteal phase of the menstrual cycle is higher than that in the follicular phase.
Side effects
Common side effects of oral Progesterone include: chest pain, chills, cold or flu-like symptoms; cough or hoarseness; fever, and problems with urination. Rare side effects include: clear or bloody discharge; dimpling of the breast skin, lumps in the breast or armpit; persistent crusting or flaking; redness or swelling of the breast; and sores on the breast skin that do not heal. Other side effects that may occur are: abdominal or stomach pain; constipation, difficulty breathing, dizziness, fast, strong, or irregular heartbeat or pulse; headache, measles, indigestion, itching, joint pain, stiffness, or swelling; rash.
Safety Profile
NTP 10th Report on Carcinogens. IARC Cancer Review: Animal Lirmted Evidence IMEMDT 21,491,79; Animal Sufficient Evidence IMEMDT 6,135,74. EPA Genetic Toxicology Program. Reported in EPA TSCA Inventory. SAFETY PROFILE: Confirmed carcinogen with experimental carcinogenic, neoplastigenic, tumorigenic, and teratogenic data. Poison by intravenous and intraperitoneal routes. Human teratogenic effects by ingestion and parenteral routes: developmental abnormalities of the urogenital system. Human male reproductive effects by intramuscular route: changes in spermatogenesis, the prostate, seminal vesicle, Cowper's gland and accessory glands, impotence, and breast development. Human female reproductive effects by ingestion, parenteral, and intravaginal routes: ferthty changes; menstrual cycle changes and disorders; uterus, cervix, and vagina changes. Experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits acrid smoke and irritating fumes.
Synthesis
Progesterone, pregn-4-en-3,20-dione (28.3.1), is made by oxidizing pregnenolon with aluminum isopropylate in the presence of cyclohexanone as a proton acceptor (Oppenauer oxidation). Pregnenolon itself is made by subsequent oxidation and further cleavage of the side chain of stigmasterin, a sterin of plant origin that is isolated from soybeans.
Carcinogenicity
Progesterone is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity from studies in experimental animals.
storage
Store at RT
Purification Methods
The form crystallises from EtOH with m 127-131o. The -form crystallises from pet ether or aqueous pet ether/aqueous Et2O with m 119-120o or 121o. It also crystallises from Et2O, Me2CO/EtOAc, MeOH, aqueous Et2O, aqueous MeOH, wet pet ether, Et2O/pet ether, pet ether/*C6H6, Et2O/pentane and isopropyl ether. The is at 240nm with log 4.25 (EtOH). [Wintersteiner & Allen J Biol Chem 107 max 321 1934, Beilstein 7 III 3648, 7 IV 2395.]
Toxics Screening Level
The ITSL for progesterone is 0.1 μg/m3 based on an annual averaging time.
References
[1] BIJAN PEDRAM. A Tissue-Selective Nonsteroidal Progesterone Receptor Modulator: 7,9-Difluoro-5-(3-methylcyclohex-2-enyl)-2,2,4-trimethyl-1,2-dihydrochromeno[3,4-f]quinoline[J]. Journal of Medicinal Chemistry, 2008, 51 13: 3696-3699. DOI: 10.1021/jm8004256
Progesterone Preparation Products And Raw materials
Raw materials
Preparation Products
1of3
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Baoji Guokang Healthchem Co., Ltd. | +86-0917-3909592 +86-13892490616 | gksales1@gk-bio.com | China | 9080 | 58 |
| Pharmaceuticals Group Corp., Ltd. | +8613004379774 | wu@jiaerke.com | China | 33 | 58 |
| Hangzhou Hyper Chemicals Limited | +86-0086-57187702781 +8613675893055 | info@hyper-chem.com | China | 310 | 58 |
| RongNa Biotechnology Co.,Ltd | +86-86-13583358881 +8618560316533 | Brad@rongnabiotech.com | China | 3364 | 58 |
| Hebei Chuanghai Biotechnology Co., Ltd | +8615350571055 | Sibel@chuanghaibio.com | China | 8738 | 58 |
| Shaanxi Dideu Medichem Co. Ltd | +8617392709771 | 1097@dideu.com | China | 3996 | 58 |
| Firsky International Trade (Wuhan) Co., Ltd | +8615387054039 | admin@firsky-cn.com | China | 427 | 58 |
| Suzhou Sanyi Polymer Chemical Technology Co., Ltd. | +8615571922873 | 15571922873@163.com | China | 102 | 58 |
| Shaanxi Haibo Biotechnology Co., Ltd | +undefined18602966907 | qinhe02@xaltbio.com | China | 997 | 58 |
| Nantong Guangyuan Chemicl Co,Ltd | +undefined17712220823 | admin@guyunchem.com | China | 615 | 58 |
Related articles
- The Mystery of Progesterone: Decoding the "Key" to Life
- Progesterone is an indispensable member of the female reproductive system, plays a pivotal role in the pregnancy, development,....
- Jun 25，2024
- Biological functions and use of Progesterone
- Progesterone (P4) is a steroid hormone and an intermediate of sex steroids produced by all steroidogenic tissues.
- Jun 15，2022
- Physiological effects of progesterone
- Progesterone, also known as progesterone hormone and progesterone hormone, is the main biologically active progesterone secret....
- Apr 11，2022
Related Qustion
Ask a questionView Lastest Price from Progesterone manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-04-29 | Progesterone
57-83-0
|
US $0.00 / kg | 1kg | 97.0～103.0%; USP42 | 3000kg/month | WUHAN FORTUNA CHEMICAL CO., LTD | |
 |
2026-04-29 | Progesterone
57-83-0
|
US $1.00 / kg | 1kg | 99% | 100kg | RongNa Biotechnology Co.,Ltd | |
 |
2026-04-29 | Progesterone
57-83-0
|
US $0.00 / kg | 1kg | 0.99 | 1000kg | Shaanxi Xianhe Biotech Co., Ltd |
-
- Progesterone
57-83-0
- US $0.00 / kg
- 97.0～103.0%; USP42
- WUHAN FORTUNA CHEMICAL CO., LTD
-
- Progesterone
57-83-0
- US $1.00 / kg
- 99%
- RongNa Biotechnology Co.,Ltd
-
- Progesterone
57-83-0
- US $0.00 / kg
- 0.99
- Shaanxi Xianhe Biotech Co., Ltd
